Publications by authors named "Kelly Godby"

Claim this Profile
R
Reversing the sequence: Efficacy of BCMA-directed therapy following progression on GPRC5D-directed therapies in relapsed multiple myeloma.
Laura Joiner, Smith Giri, Gayathri Ravi, Kelly Godby, Caitlin Hagedorn

Br J Haematol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimal MRD-based end point to support response-adapted treatment cessation in newly diagnosed multiple myeloma.
Smith Giri, Binod Dhakal, Natalie S Callander, Eva Medvedova, Kelly Godby

Blood· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NCCN Guidelines® Insights: Multiple Myeloma, Version 1.2025.
Shaji K Kumar, Natalie S Callander, Kehinde Adekola, Larry D Anderson, Muhamed Baljevic, Kelly Godby

J Natl Compr Canc Netw· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Establishing measurable residual disease trajectories for patients on treatment for newly diagnosed multiple myeloma as benchmark for deployment of T-cell redirection therapy.
Susan Bal, Tylan Magnusson, Gayathri Ravi, Smith Giri, Kelly Godby

Blood Cancer J· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implications of isolated MRD progression in newly diagnosed multiple myeloma treated with quadruplet therapy.
Luciano J Costa, Eva Medvedova, Binod Dhakal, Bhagirathbhai R Dholaria, Kelly N Godby

Blood Cancer J· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hospital Associated Disability among Older Adults with Plasma Cell Disorders Receiving Autologous Stem Cell Transplant.
Kyle Kidwell, Susan Bal, Kelly Godby, Gayathri Ravi, Luciano J Costa

Transplant Cell Ther· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating concordance between International Myeloma Working Group (IMWG) frailty score and simplified frailty scale among older adults with multiple myeloma.
Andrew Gahagan, Supriya Maheshwari, Sunil Rangarajan, Clare Ubersax, Abigail Tucker, Kelly Godby

J Geriatr Oncol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anthropometric traits and risk of multiple myeloma: differences by race, sex and diagnostic clinical features.
Kevin D Arnold, Krystle L Ong, Gayathri Ravi, Hannah Cutshall, Kalyn Purnell, Kelly N Godby

Br J Cancer· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low skeletal muscle mass and treatment outcomes among adults with haematologic malignancies: A systematic review and meta-analysis.
Nadia M Anabtawi, Monica Sai Pasala, Alyssa A Grimshaw, Prakash Kharel, Susan Bal, Kelly Godby

J Cachexia Sarcopenia Muscle· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Understanding health outcome preferences of older adults diagnosed with multiple myeloma.
Supriya Maheshwari, Miguel Arias, Clare Ubersax, Abigail Tucker, Susan Bal, Kelly Godby

J Geriatr Oncol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subsequent therapy and outcomes in patients with newly diagnosed multiple myeloma experiencing disease progression after quadruplet combinations.
Gayathri Ravi, Susan Bal, Laura Joiner, Smit Giri, Melissa Sentell, Kelly N Godby

Br J Haematol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Daratumumab-based quadruplet therapy for transplant-eligible newly diagnosed multiple myeloma with high cytogenetic risk.
Natalie S Callander, Rebecca Silbermann, Jonathan L Kaufman, Kelly N Godby, Jacob Laubach

Blood Cancer J· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Waldenström Macroglobulinemia/Lymphoplasmacytic Lymphoma, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology.
Shaji K Kumar, Natalie S Callander, Kehinde Adekola, Larry D Anderson, Muhamed Baljevic, Kelly Godby

J Natl Compr Canc Netw· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiple Myeloma, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology.
Shaji K Kumar, Natalie S Callander, Kehinde Adekola, Larry D Anderson, Muhamed Baljevic, Kelly Godby

J Natl Compr Canc Netw· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Teclistamab in patients with multiple myeloma and impaired renal function.
Laura Joiner, Susan Bal, Kelly N Godby, Luciano J Costa

Am J Hematol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of a semi-automated approach for FDG PET image analysis for routine clinical application in patients with multiple myeloma.
Tyler J Wellman, Sarah R Mudd, Kelly N Godby, Dustin W Wooten, Jeremy A Ross

Transl Oncol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Minimal residual disease response-adapted therapy in newly diagnosed multiple myeloma (MASTER): final report of the multicentre, single-arm, phase 2 trial.
Luciano J Costa, Saurabh Chhabra, Eva Medvedova, Bhagirathbhai R Dholaria, Timothy M Schmidt, Kelly N Godby

Lancet Haematol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Utility of end of induction bone marrow biopsy and survival outcomes in acute promyelocytic leukemia treated with fixed-dose induction regimen.
Sydney Dunn-Valadez, Srilakshmi Bathini, Kathleen E Purdy, Kimo Bachiashvili, Ravi Bhatia, Kelly Godby

Leuk Lymphoma· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Humoral immune reconstitution following therapy with daratumumab, carfilzomib, lenalidomide, and dexamethasone (Dara-KRd), autologous hematopoietic cell transplantation, and measurable residual disease-response-adapted treatment cessation.
Rebecca W Silbermann, Timothy Martin Schmidt, Susan Bal, Binod Dhakal, Bhagirathbhai Dholaria, Kelly N Godby

EJHaem· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of induction intensity and transplantation on outcomes of patients with complex karyotype and TP53-mutated acute myeloid leukemia.
Omer Jamy, Kendall Diebold, Kenneth Davis, Kimo Bachiashvili, Sravanti Rangaraju, Kelly N Godby

Bone Marrow Transplant· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug class refractoriness, not number of prior lines of therapy, properly classify patients with relapsed and refractory multiple myeloma.
Luciano J Costa, Smith Giri, Susan Bal, Gayathri Ravi, Kelly N Godby

Br J Haematol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systemic Light Chain Amyloidosis, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology.
Shaji K Kumar, Natalie S Callander, Kehinde Adekola, Larry D Anderson, Muhamed Baljevic, Kelly Godby

J Natl Compr Canc Netw· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dismal survival outcomes of patients with acute myeloid leukemia after failure of venetoclax with hypomethylating agents.
Carl Zainaldin, Sankalp Arora, Srilakshmi Bathini, Udita Gupta, Vishruti Pandya, Kelly Godby

Leuk Lymphoma· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disparities in clinical trial participation among older adults with multiple myeloma in the United States.
Priscila White, Abigail Cooley, Susan Bal, Kelly Godby, Gayathri Ravi

J Geriatr Oncol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of autologous hematopoietic cell transplantation on disease burden quantified by next-generation sequencing in multiple myeloma treated with quadruplet therapy.
Susan Bal, Binod Dhakal, Rebecca W Silbermann, Timothy M Schmidt, Bhagirathbhai Dholaria, Kelly N Godby

Am J Hematol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis